Advocacy News Foundation Hosts Biden Cancer Community Summit to Address Funding for Early Career Researchers
LRF News Lymphoma Research Foundation Annual Gala Raises More Than $2 Million to Advance Research and Patient Support Services
Lymphoma News U.S. Food and Drug Administration Approves Duvelisib (COPIKTRA) for Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and Follicular Lymphoma
Advocacy News Buildings and Landmarks Worldwide Join LRF to Light It Red for Blood Cancer Awareness Month
Lymphoma News U.S. Food and Drug Administration Approves Ibrutinib (IMBRUVICA) Plus Rituximab (RITUXAN) for Waldenström Macroglobulinemia (WM)
Lymphoma News U.S. Food and Drug Administration Approves Mogamulizumab-kpkc (Poteligeo) for Two Most Common Types of Cutaneous T-Cell Lymphoma
Research News Lymphoma Research Foundation Grantee, Scientific Advisory Board Chair Lead International Commission on Adverse Events in the Treatment of Lymphoma
Research News LRF Announces Research Grants in Mantle Cell Lymphoma, Lymphoma Clinical Research Mentoring Program
